Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 06, 2010 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Management to Present at World Stem Cells and Regenerative Medicine Congress

PALO ALTO, Calif., May 6, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Martin McGlynn, President and CEO, and Stewart Craig, Ph.D., Senior Vice President, Development...
May 04, 2010 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Reports First Quarter Financial Results and Highlights

PALO ALTO, Calif., May 4, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell technology company with the dual focus of novel therapeutics and innovative research products,...
May 03, 2010 09:00 ET | Source: StemCells, Inc.

StemCells, Inc.'s Phase I Batten Trial Data Featured at American Association of Neurological Surgeons Annual Meeting

PALO ALTO, Calif., May 3, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced that Nathan Selden, M.D., Ph.D., F.A.C.S., F.A.A.P., will give a feature presentation today at the American...
April 21, 2010 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Plans to Advance to Second Clinical Trial in Batten Disease

PALO ALTO, Calif., April 21, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has submitted a protocol to the FDA for initiation of a second clinical trial of its...
March 17, 2010 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Granted Broad Patent for Pluripotent Rat Stem Cells and Genetically Engineered Rats

PALO ALTO, Calif., March 17, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that the United Kingdom (UK) Intellectual Property Office has granted patent number GB2451523 with...
March 11, 2010 06:00 ET | Source: StemCells, Inc.

StemCells, Inc. Reports Fourth Quarter and Fiscal 2009 Financial Results

PALO ALTO, Calif., March 11, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today reported financial results for the fourth quarter and year ended December 31, 2009. The Company's results...
February 16, 2010 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Launches Cell Culture Medium Enabling the Derivation and Maintenance of True Mouse iPS Cells

PALO ALTO, Calif., Feb. 16, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the launch of GS2-M™, a new cell culture medium that enables the derivation and long-term...
February 10, 2010 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Announces First Human Neural Stem Cell Transplant in Landmark Myelination Disorder Trial

PALO ALTO, Calif., Feb. 10, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that its proprietary HuCNS-SC® human neural stem cells have been used to treat the first patient...
February 03, 2010 09:00 ET | Source: StemCells, Inc.

LifeTech Capital Initiates Research Coverage of StemCells, Inc. With Strong Speculative Buy Recommendation

PALO ALTO, Calif., Feb. 3, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that LifeTech Capital has initiated independent research coverage on the Company with a “Strong...
January 25, 2010 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Launches First Cell Culture Medium to Enable Derivation and Maintenance of True Rat Embryonic Stem Cells

PALO ALTO, Calif., Jan. 25, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the launch of GS1-R™, the first commercially available medium to enable the derivation,...